Table 1.

Detailed composition of the intravenous nanoemulsion developed by the works included in this review. Excipient and drug quantities and units are shown as reported in the respective articles (w/w%). For the excipients, usually the brand name was used (when available).

Composition		Intravenous Aripiprazole o/w Nanoemulsion [34]
Oil	Palm kernel oil esters	3.00% w/w
Hydrophobic surfactant	Lipoid S75 1	2.00% w/w
Hydrophilic surfactant	Tween® 80 2	1.00% w/w
Cosolvent	Glycerol	2.25% w/w
Water	-	91.75% w/w
Drug	Aripiprazole	0.10% w/w

¹ soybean lecithin; ² polysorbate 80—polyoxyethylene 20 sorbitan monooleate.